FDA Approves Alymsys (bevacizumab-maly), a Biosimilar to Avastin

BRIDGEWATER, N.J.--(BUSINESS WIRE) April 13, 2022 --Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the“Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news